Mucoplant Forte (Dry Extract Of Hederae Folium (Der 4-8:1), Extracting Agent: Ethanol 30 % (M/M))

The extract is rich in saponins and flavonoids that stimulate the glands lining the bronchial tree, increasing the volume and reducing the viscosity of airway mucus. This promotes more effective clearance of secretions. Additionally, the constituents exert a mild relaxant effect on bronchial smooth muscle, which can widen the airways and support a more productive cough reflex.

The appropriate dose of Mucoplant Forte is determined by a qualified healthcare professional based on the patient’s age, weight, and clinical condition. The prescriber will specify the exact amount, frequency, and duration of therapy on the product label or prescription. Patients should follow the healthcare provider’s instructions and not exceed the recommended amount.

Safety data for Hedera helix leaf extract in pregnancy and lactation are limited. Consequently, the product should be used only if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a healthcare professional. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their physician before starting therapy.

To request Mucoplant Forte, visit the product page on gnhindia.com and submit an enquiry specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials. After verification, the sales team provides pricing, availability, shipping details—including any special handling—and assists with the necessary import documentation.

Compared with synthetic expectorants such as guaifenesin, Mucoplant Forte offers a herbal alternative that combines mucus‑stimulating saponins with mild smooth‑muscle relaxation. While both classes aim to facilitate sputum clearance, the herbal extract may be preferred by patients seeking natural products. Efficacy and tolerability can vary, so clinicians consider individual patient response, potential allergies, and drug‑interaction profiles when selecting therapy.

Mucoplant Forte should be stored at ambient temperature, ideally below 25 °C (77 °F). Keep the product in its original packaging to protect it from moisture, humidity, and direct sunlight. Ensure the container is tightly closed when not in use, and keep it out of reach of children. Do not refrigerate or freeze unless specifically instructed on the label.

The product is taken orally, usually as a tablet, capsule, or liquid preparation, depending on the marketed dosage form. The patient should swallow the dose with a glass of water, unless the label advises otherwise. Administration should follow the prescribing clinician’s directions regarding timing, such as taking it with or without food, to optimize absorption and effectiveness.

Although generally well tolerated, serious adverse reactions can occur. These include allergic responses such as rash, itching, swelling of the face or tongue, and in rare cases, bronchospasm that may worsen breathing difficulty. Hepatic enzyme elevations have been reported infrequently. Patients experiencing any of these symptoms should discontinue the product and seek immediate medical attention.

Individuals with a known hypersensitivity to Hedera helix leaf or any component of the formulation should avoid Mucoplant Forte. It is also contraindicated in children younger than two years unless specifically prescribed by a pediatric specialist. Patients taking strong antitussive agents, certain CYP450 inhibitors, or those with uncontrolled asthma should consult a healthcare professional before use.